Jonathan Chang
Analyst, Liver Inc. Partners
Replay available
Zai Lab Limited (NASDAQ: ZLAB) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Analyst, Liver Inc. Partners
Analyst, Kantor
Analyst, Morgan Stanley
Analyst, Goldman Sachs
Analyst, JP Morgan
President and Head of Global Research and Development
President and Chief Operating Officer
Analyst, Citigroup
Senior Vice President, Investor Relations
Chief Financial Officer
Founder, Chief Executive Officer and Chairperson
Hello, ladies and gentlemen. Thank you for standing by, and welcome to Xylep's second quarter 2025 financial results conference call. At this time, all participants are in the listen-only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, today's call is being recorded. It is now my pleasure to turn the floor over to Christine Cho, Senior Vice President of Investor Relations. Please go ahead, ma'am. Thank you, operator. Hello and welcome, everyone. Today's earnings call will be led by Dr. Samantha Du, Xilab's founder, CEO, and chairperson. She will be joined by Josh Smiley, President and Chief Operating Officer, Dr. Rafael Amado, President and Head of Global Research and Development, and Dr. Yajing Chen, Chief Financial Officer. Jonathan Wang, our Chief Business Officer, will also be available to answer questions during the Q&A portion of the call. As a reminder, during today's call, we will be making certain forward-looking statements based on our current expectations. These statements are subject to numerous risks and uncertainties that may cause actual results to differ materially from what we expect due to a variety of factors, including those discussed in our SEC filings. We will also refer to adjusted loss from operations, which is a non-GAAP financial measure. please refer to our earnings release furnished with the SEC on August 7, 2025, for additional information on this non-GAAP financial measure. At this time, it is my pleasure to turn the call over to Dr. Samantha Du. Thank you, Christine. Good morning and good evening, everyone. Thank you for joining us today. As we reach the midpoint of 2025, satellite is entering a pivotal phase. killing our commercial business, advancing our global pipe...